- LATEST
- WEBSTORY
- TRENDING
HEALTH
New patch for diabetics may replace insulin injections
Diabetes patients who used the new OneTouch Via mealtime, on-demand insulin delivery system missed fewer doses and felt less stress about dosing compared to multiple daily injections
Updated : Jun 12, 2016, 12:42 PM IST
 "Diabetes patch")
TRENDING NOW
)
Shilpa Shetty breaks down, Salman Khan cancels shoot; celebs rush to Lilavati hospital after Baba Siddique shot dead
)
Anushka Sharma shares FIRST photo of Akaay, Vamika to celebrate Virat Kohli's birthday
)
Aishwarya Rai's biggest flop was rejected by Priyanka Chopra, ruined director's career, didn't earn even Rs 10 crore
)
Meet Kartik Aaryan's 'sister', started career with 8 flops, then charged more than SRK, Salman, Aamir; quit films for...
)
Good news for Anil Ambani, another Reliance company becomes debt-free, prepays Rs 4850000000 crore to...
)
Amid divorce rumours, video of Abhishek Bachchan, Aishwarya Rai and Aaradhya dancing together goes viral
)
Pakistani TikTok star Minahil Malik reacts after leaked video with boyfriend goes viral, says, 'I'm done...'
)
Mukesh Ambani, Nita Ambani's son Akash Ambani's favourite food is this dish that only costs only Rs 500
)
After Arjun Kapoor confirms his breakup with Malaika Arora, her statement goes viral: 'Somebody else out there is...'
)
Mukesh Ambani's SUPERHIT new plan for Jio users, offers 100 GB of free cloud storage for just Rs...
)
Meet actress who ruled box office in 1994, did 8 films in 1 year, competed with Akshay Kumar, Ajay Devgn, Govinda, now..
)
ED raids main vendors of Amazon, Flipkart across multiple cities, including Delhi, Mumbai due to...
)
7 times Gandi Baat and XXX show actress Aabha Paul impressed fans on Instagram
)
Salman Khan worked in this film against everyone's will, called his character 'loser', made for Rs 10 crore, it earned..
)
Amid Bhool Bhulaiyaa 3's success, Akshay Kumar to bring sequel of this blockbuster with OG cast, will reunite with..
While syringes, pens, pumps and jet injectors have given diabetics options for their insulin delivery for many years now, a new device called OneTouch Via could change the game.
People with type 1 and type 2 diabetes who used the new OneTouch Via mealtime, on-demand insulin delivery system reported they missed fewer doses and felt less stress about dosing compared to multiple daily injections, according to research presented by Calibra Medical Inc, one of the Johnson & Johnson Diabetes Care Companies, at the annual American Diabetes Association (ADA) conference.
Results of the Market Acceptance Evaluation (MAE) study also demonstrated that physicians were more likely to recommend the innovative insulin delivery device to patients who are not at A1C goals or who are new to rapid-acting insulin (RAI) therapy.
The new OneTouch Via is a wearable, on-demand insulin delivery system in development that allows patients to discreetly deliver rapid-acting, or bolus, insulin at mealtimes by simply pressing two buttons on the device, accessible even through clothing. The thin, water-resistant patch can be worn continuously for up to three days, providing injection-free delivery of insulin when needed.
"People with diabetes can often feel embarrassment or discomfort when they need to inject insulin at mealtimes or when snacking. In a social situation, they may choose to miss a dose so they don't have to take themselves out of the moment, but avoiding needed insulin doses may lead to serious health complications over time," said Dr. Brian Levy.
Levy added, “Because patients in the study were empowered to dose discreetly with the OneTouch Via, they felt encouraged to dose more often - and ultimately, they reported missing fewer doses and better adherence to their treatment regimen."
The healthcare professionals who assisted with the study noted that they preferred the OneTouch Via over both insulin pens and syringes (75 % and 100 % respectively) and would be likely to recommend it to their patients. The doctors also reported that they would start patients on mealtime insulin earlier because of the ease of use of the OneTouch Via patch.
The study was presented at the American Diabetes Association (ADA) Conference.
